Papers: 10.1371/journal.pone.0035857

https://doi.org/10.1371/journal.pone.0035857

DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma

Cited by: 27
Author(s): Stefanie Galbán, Benjamin Lemasson, Terence M. Williams, Fēi Li, Kevin Heist, Timothy D. Johnson, Judith Leopold, Thomas L. Chenevert, Theodore S. Lawrence, Alnawaz Rehemtulla, Tom Mikkelsen, Eric C. Holland, Craig J. Galbán, Brian D. Ross
Published: over 14 years ago

Software Mentions 1